A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer

Urologia Internationalis

Volumn 63, Issue 2, 1999, Pages 120-125

  Senderowicz, Adrian M ^a   Reid, Robert ^a   Headlee, Donna ^a   Abornathy, Troy ^a   Horti, József ^a   Lush, Richard M ^a   Reed, Eddie ^a   Figg, William D ^a   Sausville, Edward A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anemia; Atomic absorption spectrometry; Heavy metal; Hormone, refractory; Pharmacokinetics; Prostate specific antigen; Toxicity; Vision loss

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; GALLIUM NITRATE; LEUPRORELIN; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN; SURAMIN;

ADULT; AGED; ANEMIA; ARTICLE; BLINDNESS; CASTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEVER; HEADACHE; HUMAN; HYPOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFILTRATE; MALE; METASTASIS; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; VOMITING;

EID: 0032699128     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030430     Document Type: Article

References (21)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998; 48:6-29.
2. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989;321:419-424.
3. Seidman AD, Scher HI: The evolving role of chemotherapy for muscle infiltrating bladder cancer. Semin Oncol 1991;18:585-595.
4. Baselga J, Kris MG, Scher HI, Phillips M. Heelan RT: Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer. Invest New Drugs 1993;11:85-86.
5. Warrell RP Jr, Danieu L, Coonley CJ, Atkins C: Salvage chemotherapy of advanced lymphoma with investigational drugs: Mitoguazone, gallium nitrate, and etoposide. Cancer Treat Rep 1987;71:47-51.
6. Keller J, Bartolucci A, Carpenter JT Jr, Feagler J: Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: A Southeastern Cancer Study Group trial. Cancer Treat Rep 1986;70:1221-1223.
7. Chitambar CR, Zahir SA, Ritch PS, Anderson T: Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma. Am J Clin Oncol 1997;20:173-178.
8. Todd PA, Fitton A: Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer-related hypercalcaemia. Drugs 1991;42:261-273.
9. Moreno AJ, Swaney JJ, Spicer MJ, Henry CD, Turnbull GL: The gallium-67 citrate bone scan. Clin Nucl Med 1985;10:594-595.
10. Edwards CL, Hayes RL: Scanning malignant neoplasms with gallium 67. JAMA 1970;212: 1182-1191.
11. Hart MM, Smith CF, Yancey ST, Adamson RH: Toxicity and antitumor activity of gallium nitrate and periodically related metal salts. J Natl Cancer Inst 1971;47:1121-1127.
12. Larson SM, Rasey JS, Allen DR, Nelson NJ, Grunbaum Z, Harp GD, Williams DL: Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. J Natl Cancer Inst 1980;64:41-53.
13. Chitambar CR, Narasimhan J, Guy J, Sem DS, O'Brien WJ: Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res 1991;51:6199-6201.
14. Berggren MM, Burns LA, Abraham RT, Powis G: Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate. Cancer Res 1993;53:1862-1866.
15. Scher HI, Curley T, Geller N, Dershaw D, Chan E, Nisselbaum J, Alcock N, Hollander P, Yagoda A: Gallium nitrate in prostatic cancer: Evaluation of antitumor activity and effects on bone turnover. Cancer Treat Rep 1987;71: 887-893.
16. Reed E, SauerhoffS, Poirier MC: Quantitation of platinum-DNA binding in human tissues following therapeutic levels of drug exposure -A novel use of graphite furnace spectrometry. Atomic Spectroscopy 1988;9:93-95.
17. Warrell RP Jr, Bockman RS, Coonley CJ, Isaacs M, Staszewski H: Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hyperealcemia. J Clin Invest 1984;73:1487-1490.
18. Warrell RP Jr, Alcock NW, Bockman RS: Gallium nitrate inhibits accelerated bone turnover in patients w th bone metastases. J Clin Oncol 1937;5:292-298.
19. Blair HC, Teitelbaum SL, Tan HL, Schlesinger PH: Reversible inhibition of osteoclastic activity by bone-bound gallium (III). J Cell Biochem 1992;48:401-410.
20. Einhorn LH, Roth BJ, Ansari R, Dreícer R, Gonin R, Loehrer PJ: Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. J Clin Oncol 1994;12:2271-2276.
21. Dixon SC, Zalles A, Giordano C, Lush RM, Venzon D, Reed E, Figg WD: In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3. Cancer Lett 1997;113:111-116.